Discovery Science
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect disease risk and severity. Their research could lead to new therapies in the future.
Latest stories
Featured News
Gastric acid suppression medications increase risk for recurrence of Clostridium difficile infection
March 27, 2017
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community